FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/069041 [Registered on: 18/06/2024] Trial Registered Prospectively
Last Modified On: 12/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [MIDWIFERY LED COMPREHENSIVE CARE APPROACH]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Midwifery-led care intervention to improve perinatal outcome in women with Hypertensive Disorders of Pregnancy. 
Scientific Title of Study   Effect of midwifery led comprehensive care approach on perinatal outcome among women with Hypertensive disorders at Sum Hospitals of Bhubaneswar, Odisha  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  MADHUSMITA NAYAK 
Designation  ASSISTANT PROFESSOR 
Affiliation  SUM NURSING COLLEGE, BHUBANESWAR 
Address  ROOM No- 4, SECOND FLOOR, SUM NURSING COLLEGE, BHUBANESWAR.

Khordha
ORISSA
751003
India 
Phone  08847852784  
Fax    
Email  madhusmitanayak@soa.ac.in  
 
Details of Contact Person
Scientific Query
 
Name  DR PRAVATI TRIPATHY 
Designation  DEAN 
Affiliation  SUM NURSING COLLEGE, BHUBANESWAR 
Address  DEAN ROOM, GROUND FLOOR, SUM NURSING COLLEGE, BHUBANESWAR

Khordha
ORISSA
751003
India 
Phone  9437035927  
Fax    
Email  dean.snc@soa.ac.in  
 
Details of Contact Person
Public Query
 
Name  DR PRAVATI TRIPATHY 
Designation  DEAN 
Affiliation  SUM NURSING COLLEGE, BHUBANESWAR 
Address  DEAN ROOM, GROUND FLOOR, SUM NURSING COLLEGE, BHUBANESWAR

Khordha
ORISSA
751003
India 
Phone  9437035927  
Fax    
Email  dean.snc@soa.ac.in  
 
Source of Monetary or Material Support  
SUM Nursing College, Faculty of nursing, campus-2,Siksha O Anushandhan DTU, Bhubaneswar, Odisha, india, Pin- 751003 
 
Primary Sponsor  
Name  Madhusmita Nayak 
Address  SUM Nursing College,Faculty of nuring, Campus-2, K-8, Kainganagar, Bhubaneswar, Odisha, India, Pin- 751003 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR PRAVATI TRIPATHY  INSTITUTE OF MEDICAL SCIENCE & SUM HOPSITAL  Room No-1, ANTENATAL OPD, GROUND FLOOR, DEPARTMENT OF OBSTETRICS
Khordha
ORISSA 
9437035927

dean.snc@soa.ac.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE, INSTITUTE OF MEDICAL SCIENCES (IMS) AND SUM HOSPIAL, SIKSHA O ANUSHANDHAN (DEEMED TO BE UNIVERSITY)(ACCREDITATED BY NAAC OF UGC WITH A GRADE)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O140||Mild to moderate pre-eclampsia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  control Group  In control group, the women diagnosed with HDP, will receive the standard treatment 
Intervention  MIDWIFERY LED COMPREHENSIVE CARE APPROACH  Midwifery led comprehensive care approach includes an educational session for women with diagnosed HDP for 60min in first visit (regarding Risk analysis, regular antenatal visits, Daily fetal movement count (DFMC), Home BP monitoring and recording, DASH diet, exercise details, drugs and use of safe pregnancy & birth mobile App), Appropriate intrapartum monitoring & care and postpartum follow up (6weeks) through what’s app group. This care was provided by a registered midwife. Self-daily home monitoring with recording includes BP (if possible), Fetal movement count, visible abnormal weight gain, pedal edema. Immediate information should be given to midwifery I/C if the BP exceeds 140/90mmhg, fetal movement is 10 in 12 hr/day for 2 consecutive days or no fetal movement/24hr, any abnormal weight gain (not because of pregnancy) and presence of pedal edema. Apart from that weekly feedback was taken by the midwife telephonically. Total 5 contact visits was there at 20weeks, 22-30week, 31-36week, 36-delivery and at the time of delivery antenatally and 1 contact visit postnatally and the parameters like FHR, BP, weight gain and proteinuria was checked post to the intervention. This program was developed after consultation with Obstetrician and dietician experts and was validated before use.  
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  48.00 Year(s)
Gender  Female 
Details  1- All women with Hypertensive disorders of pregnancy
2- At any Gestational age
3- Must have minimum of 5 contact visit antenatally and 1 contact postnatally.
4- Availability of complete records 
 
ExclusionCriteria 
Details  1- Women attending OPD first time after 30 week of gestation

2- women with HDP who declined to participate in the study

3- Those with hypertension who delivered in other health facilities

4- mothers with comorbid chronic medical disorders like diabetes, severe anemia, renal disease, cardiac disease.

5- Mothers with epilepsy
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1. Perinatal outcome among women with HDP  after 20week of gestation up to delivery. 
 
Secondary Outcome  
Outcome  TimePoints 
1. Maternal satisfaction
2. Quality of life
3. Adherence to medication 
after 20week of gestation up to delivery. 
 
Target Sample Size   Total Sample Size="146"
Sample Size from India="146" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   30/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Primary purpose of the protocol: As because the hypertensive disorders of pregnancy is contributing to both maternal & neonatal mortality in India. Hence the authors has come up with this trial to introduce an midwifery led intervention with continuous follow up of mothers up till the delivery and postnatal period as well to see its effect on the perinatal outcome. 

Hypothesis: 
1.H01:there is no significant difference between post test score of experimental and control group in terms of perinatal outcome.
2. H02:there is no significant difference between post test score of experimental and control group in terms of maternal satisfaction.
3.H03 : There is no significant change in mothers blood pressure, BMI & FHR before, during and after receiving intervention
4.H04 : there is no significant association between perinatal outcome and maternal satisfaction with selected sociodemographic variable

 
Close